SeaStar Medical (ICU) Competitors

SeaStar Medical logo
$0.78 -0.07 (-8.49%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$0.80 +0.02 (+1.92%)
As of 08:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICU vs. TELA, QTEX, IINN, ELUT, and NSPR

Should you buy SeaStar Medical stock or one of its competitors? SeaStar Medical's main competitors and comparable companies include TELA Bio (TELA), QTREX Quantum (QTEX), Inspira Technologies OXY B.H.N. (IINN), Elutia (ELUT), and InspireMD (NSPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SeaStar Medical compare to TELA Bio?

SeaStar Medical (NASDAQ:ICU) and TELA Bio (NASDAQ:TELA) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk, media sentiment and analyst recommendations.

SeaStar Medical has a beta of -1.07, indicating that its share price is 207% less volatile than the broader market. Comparatively, TELA Bio has a beta of 1.46, indicating that its share price is 46% more volatile than the broader market.

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 94.4% of TELA Bio shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 1.1% of TELA Bio shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

TELA Bio has a net margin of -53.57% compared to SeaStar Medical's net margin of -678.24%. SeaStar Medical's return on equity of -261.10% beat TELA Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-678.24% -261.10% -149.15%
TELA Bio -53.57%-1,320.81%-60.17%

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 924.33%. TELA Bio has a consensus price target of $2.14, suggesting a potential upside of 181.18%. Given SeaStar Medical's higher possible upside, analysts plainly believe SeaStar Medical is more favorable than TELA Bio.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
TELA Bio
1 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.50

SeaStar Medical has higher earnings, but lower revenue than TELA Bio. TELA Bio is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M3.38-$12.15M-$3.64N/A
TELA Bio$80.28M0.35-$38.83M-$0.74N/A

In the previous week, SeaStar Medical had 7 more articles in the media than TELA Bio. MarketBeat recorded 9 mentions for SeaStar Medical and 2 mentions for TELA Bio. TELA Bio's average media sentiment score of 0.48 beat SeaStar Medical's score of 0.04 indicating that TELA Bio is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
TELA Bio
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

TELA Bio beats SeaStar Medical on 10 of the 15 factors compared between the two stocks.

How does SeaStar Medical compare to QTREX Quantum?

QTREX Quantum (NASDAQ:QTEX) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

SeaStar Medical has higher revenue and earnings than QTREX Quantum.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
QTREX Quantum$290K135.12-$13.22MN/AN/A
SeaStar Medical$1.23M3.38-$12.15M-$3.64N/A

QTREX Quantum has a beta of 3.97, indicating that its share price is 297% more volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.07, indicating that its share price is 207% less volatile than the broader market.

SeaStar Medical has a consensus price target of $8.00, suggesting a potential upside of 924.33%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than QTREX Quantum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
QTREX Quantum
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

12.7% of QTREX Quantum shares are held by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are held by institutional investors. 29.4% of QTREX Quantum shares are held by company insiders. Comparatively, 0.7% of SeaStar Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

QTREX Quantum has a net margin of 0.00% compared to SeaStar Medical's net margin of -678.24%. QTREX Quantum's return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
QTREX QuantumN/A N/A N/A
SeaStar Medical -678.24%-261.10%-149.15%

In the previous week, SeaStar Medical had 6 more articles in the media than QTREX Quantum. MarketBeat recorded 9 mentions for SeaStar Medical and 3 mentions for QTREX Quantum. QTREX Quantum's average media sentiment score of 0.73 beat SeaStar Medical's score of 0.04 indicating that QTREX Quantum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
QTREX Quantum
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

QTREX Quantum beats SeaStar Medical on 8 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to Inspira Technologies OXY B.H.N.?

SeaStar Medical (NASDAQ:ICU) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

SeaStar Medical has a beta of -1.07, indicating that its share price is 207% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to SeaStar Medical's net margin of -678.24%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-678.24% -261.10% -149.15%
Inspira Technologies OXY B.H.N. N/A N/A N/A

In the previous week, SeaStar Medical had 6 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 9 mentions for SeaStar Medical and 3 mentions for Inspira Technologies OXY B.H.N.. Inspira Technologies OXY B.H.N.'s average media sentiment score of 0.22 beat SeaStar Medical's score of 0.04 indicating that Inspira Technologies OXY B.H.N. is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

1.7% of SeaStar Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

SeaStar Medical has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M3.38-$12.15M-$3.64N/A
Inspira Technologies OXY B.H.N.$289K143.05-$13.22MN/AN/A

SeaStar Medical presently has a consensus price target of $8.00, suggesting a potential upside of 924.33%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Inspira Technologies OXY B.H.N. beats SeaStar Medical on 8 of the 14 factors compared between the two stocks.

How does SeaStar Medical compare to Elutia?

Elutia (NASDAQ:ELUT) and SeaStar Medical (NASDAQ:ICU) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, earnings, media sentiment, dividends, profitability, risk and institutional ownership.

SeaStar Medical has a consensus target price of $8.00, indicating a potential upside of 924.33%. Given SeaStar Medical's stronger consensus rating and higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Elutia.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elutia
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

74.0% of Elutia shares are owned by institutional investors. Comparatively, 1.7% of SeaStar Medical shares are owned by institutional investors. 17.8% of Elutia shares are owned by company insiders. Comparatively, 0.7% of SeaStar Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, SeaStar Medical had 7 more articles in the media than Elutia. MarketBeat recorded 9 mentions for SeaStar Medical and 2 mentions for Elutia. SeaStar Medical's average media sentiment score of 0.04 beat Elutia's score of -0.18 indicating that SeaStar Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elutia
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Elutia has a net margin of 546.70% compared to SeaStar Medical's net margin of -678.24%. Elutia's return on equity of -140.53% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Elutia546.70% -140.53% -54.54%
SeaStar Medical -678.24%-261.10%-149.15%

Elutia has higher revenue and earnings than SeaStar Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Elutia, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elutia$12.29M3.08$53.38M$1.110.77
SeaStar Medical$1.23M3.38-$12.15M-$3.64N/A

Elutia has a beta of 0.93, meaning that its share price is 7% less volatile than the broader market. Comparatively, SeaStar Medical has a beta of -1.07, meaning that its share price is 207% less volatile than the broader market.

Summary

Elutia beats SeaStar Medical on 10 of the 16 factors compared between the two stocks.

How does SeaStar Medical compare to InspireMD?

SeaStar Medical (NASDAQ:ICU) and InspireMD (NYSE:NSPR) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, media sentiment, institutional ownership and valuation.

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 25.0% of InspireMD shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 924.33%. InspireMD has a consensus price target of $4.50, indicating a potential upside of 592.31%. Given SeaStar Medical's higher possible upside, equities analysts clearly believe SeaStar Medical is more favorable than InspireMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00

SeaStar Medical has a beta of -1.07, indicating that its share price is 207% less volatile than the broader market. Comparatively, InspireMD has a beta of 0.92, indicating that its share price is 8% less volatile than the broader market.

SeaStar Medical has higher earnings, but lower revenue than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than SeaStar Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M3.38-$12.15M-$3.64N/A
InspireMD$10.84M2.79-$19.92M-$0.59N/A

In the previous week, InspireMD had 4 more articles in the media than SeaStar Medical. MarketBeat recorded 13 mentions for InspireMD and 9 mentions for SeaStar Medical. InspireMD's average media sentiment score of 0.46 beat SeaStar Medical's score of 0.04 indicating that InspireMD is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
InspireMD
3 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

InspireMD has a net margin of -413.96% compared to SeaStar Medical's net margin of -678.24%. InspireMD's return on equity of -69.42% beat SeaStar Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-678.24% -261.10% -149.15%
InspireMD -413.96%-69.42%-57.68%

Summary

InspireMD beats SeaStar Medical on 12 of the 16 factors compared between the two stocks.

Get SeaStar Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICU and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICU and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICU vs. The Competition

MetricSeaStar MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.54M$5.99B$7.83B$11.74B
Dividend YieldN/A1.68%2.47%4.47%
P/E Ratio-0.2138.0633.9728.44
Price / Sales3.385.398.495.70
Price / CashN/A23.6221.0121.90
Price / Book8.684.174.453.72
Net Income-$12.15M$143.92M$3.52B$393.10M
7 Day Performance-59.32%-5.44%-5.94%-5.77%
1 Month Performance-73.07%-3.64%-4.58%-7.14%
1 Year Performance-76.69%-0.05%-1.95%-7.47%

SeaStar Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICU
SeaStar Medical
3.508 of 5 stars
$0.78
-8.5%
$8.00
+924.3%
-74.2%$4.54M$1.23MN/A17
TELA
TELA Bio
3.1416 of 5 stars
$0.80
-7.5%
$2.14
+167.9%
-33.1%$39.03M$80.28MN/A218
QTEX
QTREX Quantum
1.5533 of 5 stars
$1.02
-3.8%
N/AN/A$38.11M$290KN/A41
IINN
Inspira Technologies OXY B.H.N.
0.0673 of 5 stars
$1.06
+2.9%
N/A+25.1%$38.11M$289KN/A20
ELUT
Elutia
0.8244 of 5 stars
$0.93
+11.6%
N/A+16.9%$37.02M$12.29MN/A26

Related Companies and Tools


This page (NASDAQ:ICU) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners